Net Income (Loss) Attributable to Parent in USD of STANDARD BIOTOOLS INC. from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Standard Biotools Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q2 2010 to Q3 2025.
  • Standard Biotools Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$34.7M, a 28.8% decline year-over-year.
  • Standard Biotools Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$128M, a 2.94% decline year-over-year.
  • Standard Biotools Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$139M, a 86% decline from 2023.
  • Standard Biotools Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$74.7M, a 60.7% increase from 2022.
  • Standard Biotools Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$190M, a 221% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

STANDARD BIOTOOLS INC. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$128M -$34.7M -$7.75M -28.8% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025
Q2 2025 -$121M -$33.5M +$12.3M +26.8% 01 Apr 2025 30 Jun 2025 10-Q 04 Nov 2025
Q1 2025 -$133M -$26M +$6.12M +19% 01 Jan 2025 31 Mar 2025 10-Q 04 Nov 2025
Q4 2024 -$139M -$34.1M -$14.3M -72.3% 01 Oct 2024 31 Dec 2024 10-K 11 Mar 2025
Q3 2024 -$125M -$26.9M -$5.94M -28.3% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025
Q2 2024 -$119M -$45.7M -$28.7M -168% 01 Apr 2024 30 Jun 2024 10-Q 04 Nov 2025
Q1 2024 -$90M -$32.2M -$15.3M -90.9% 01 Jan 2024 31 Mar 2024 10-Q 04 Nov 2025
Q4 2023 -$74.7M -$19.8M +$1.07M +5.13% 01 Oct 2023 31 Dec 2023 10-K 11 Mar 2025
Q3 2023 -$75.7M -$21M +$8.43M +28.6% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024
Q2 2023 -$84.2M -$17M +$46.5M +73.2% 01 Apr 2023 30 Jun 2023 10-Q 06 Nov 2024
Q1 2023 -$131M -$16.8M +$59.4M +77.9% 01 Jan 2023 31 Mar 2023 10-Q 06 Nov 2024
Q4 2022 -$190M -$20.8M -$11.4M -121% 01 Oct 2022 31 Dec 2022 10-K 11 Mar 2025
Q3 2022 -$179M -$29.4M -$15.6M -113% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023
Q2 2022 -$163M -$63.5M -$46.4M -271% 01 Apr 2022 30 Jun 2022 10-Q 07 Nov 2023
Q1 2022 -$117M -$76.3M -$57.5M -305% 01 Jan 2022 31 Mar 2022 10-Q 07 Nov 2023
Q4 2021 -$59.2M -$9.43M +$8.6M +47.7% 01 Oct 2021 31 Dec 2021 10-K 14 Mar 2023
Q3 2021 -$67.8M -$13.8M -$7.84M -131% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 -$60M -$17.1M -$4.13M -31.7% 01 Apr 2021 30 Jun 2021 10-Q 09 Nov 2022
Q1 2021 -$55.9M -$18.8M -$2.84M -17.8% 01 Jan 2021 31 Mar 2021 10-Q 09 Nov 2022
Q4 2020 -$53M -$18M -$5.34M -42.1% 01 Oct 2020 31 Dec 2020 10-K 08 Mar 2022
Q3 2020 -$47.7M -$6M +$6.89M +53.4% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 -$54.6M -$13M +$738K +5.37% 01 Apr 2020 30 Jun 2020 10-Q 09 Nov 2021
Q1 2020 -$55.3M -$16M +$9.49M +37.2% 01 Jan 2020 31 Mar 2020 10-Q 09 Nov 2021
Q4 2019 -$64.8M -$12.7M +$2.09M +14.1% 01 Oct 2019 31 Dec 2019 10-K 08 Mar 2022
Q3 2019 -$66.9M -$12.9M +$1.86M +12.6% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 -$68.7M -$13.8M +$2.49M +15.3% 01 Apr 2019 30 Jun 2019 10-Q 09 Nov 2020
Q1 2019 -$71.2M -$25.5M -$12.2M -92.2% 01 Jan 2019 31 Mar 2019 10-Q 09 Nov 2020
Q4 2018 -$59M -$14.8M -$4.32M -41.3% 01 Oct 2018 31 Dec 2018 10-K 25 Feb 2021
Q3 2018 -$54.7M -$14.8M +$1.19M +7.49% 01 Jul 2018 30 Sep 2018 10-Q 08 Nov 2019
Q2 2018 -$55.9M -$16.2M +$692K +4.09% 01 Apr 2018 30 Jun 2018 10-Q 08 Nov 2019
Q1 2018 -$56.6M -$13.2M +$3.96M +23% 01 Jan 2018 31 Mar 2018 10-Q 08 Nov 2019
Q4 2017 -$60.5M -$10.5M +$7.24M +40.9% 01 Oct 2017 31 Dec 2017 10-K 27 Feb 2020
Q3 2017 -$67.8M -$15.9M +$3.85M +19.4% 01 Jul 2017 30 Sep 2017 10-Q 06 Nov 2018
Q2 2017 -$71.6M -$16.9M +$1.68M +9.05% 01 Apr 2017 30 Jun 2017 10-Q 08 Aug 2018
Q1 2017 -$73.3M -$17.2M +$2.68M +13.5% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018
Q4 2016 -$76M -$17.7M -$4.82M -37.4% 01 Oct 2016 31 Dec 2016 10-K 18 Mar 2019
Q3 2016 -$71.2M -$19.8M -$10.5M -113% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2017
Q2 2016 -$60.6M -$18.6M -$3.38M -22.2% 01 Apr 2016 30 Jun 2016 10-Q 08 Aug 2017
Q1 2016 -$57.3M -$19.9M -$3.95M -24.8% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017
Q4 2015 -$53.3M -$12.9M -$1.94M -17.7% 01 Oct 2015 31 Dec 2015 10-K 08 Mar 2018
Q3 2015 -$51.4M -$9.27M +$4.52M +32.8% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016
Q2 2015 -$55.9M -$15.2M -$2.55M -20.1% 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016
Q1 2015 -$53.3M -$15.9M -$517K -3.35% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016
Q4 2014 -$52.8M -$10.9M -$6.3M -136% 01 Oct 2014 31 Dec 2014 10-K 03 Mar 2017
Q3 2014 -$46.5M -$13.8M -$9.5M -222% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015
Q2 2014 -$37M -$12.7M -$8.64M -213% 01 Apr 2014 30 Jun 2014 10-Q 10 Aug 2015
Q1 2014 -$28.4M -$15.4M -$11.9M -334% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015
Q4 2013 -$16.5M -$4.64M -$1.04M -28.9% 01 Oct 2013 31 Dec 2013 10-K 29 Feb 2016
Q3 2013 -$15.5M -$4.29M -$134K -3.23% 01 Jul 2013 30 Sep 2013 10-Q 06 Nov 2014
Q2 2013 -$15.4M -$4.05M +$534K +11.7% 01 Apr 2013 30 Jun 2013 10-Q 04 Aug 2014
Q1 2013 -$15.9M -$3.55M +$3.14M +46.9% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014
Q4 2012 -$19M -$3.6M -$145K -4.19% 01 Oct 2012 31 Dec 2012 10-K 26 Feb 2015
Q3 2012 -$18.9M -$4.15M +$337K +7.51% 01 Jul 2012 30 Sep 2012 10-Q 07 Nov 2013
Q2 2012 -$19.2M -$4.58M +$2.61M +36.3% 01 Apr 2012 30 Jun 2012 10-Q 07 Aug 2013
Q1 2012 -$21.8M -$6.69M +$648K +8.83% 01 Jan 2012 31 Mar 2012 10-Q 09 May 2013
Q4 2011 -$22.5M -$3.46M 01 Oct 2011 31 Dec 2011 10-K 12 Mar 2014
Q3 2011 -$4.49M -$1.11M -32.8% 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012
Q2 2011 -$7.19M -$2.37M -49.1% 01 Apr 2011 30 Jun 2011 10-Q 14 Aug 2012
Q1 2011 -$7.34M 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012
Q3 2010 -$3.38M 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011
Q2 2010 -$4.82M 01 Apr 2010 30 Jun 2010 10-Q 09 Aug 2011

STANDARD BIOTOOLS INC. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$139M -$64.2M -86% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2025
2023 -$74.7M +$115M +60.7% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025
2022 -$190M -$131M -221% 01 Jan 2022 31 Dec 2022 10-K 11 Mar 2025
2021 -$59.2M -$6.22M -11.7% 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2023
2020 -$53M +$11.8M +18.2% 01 Jan 2020 31 Dec 2020 10-K 08 Mar 2022
2019 -$64.8M -$5.78M -9.79% 01 Jan 2019 31 Dec 2019 10-K 08 Mar 2022
2018 -$59M +$1.52M +2.51% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021
2017 -$60.5M +$15.5M +20.3% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020
2016 -$76M -$22.7M -42.5% 01 Jan 2016 31 Dec 2016 10-K 18 Mar 2019
2015 -$53.3M -$485K -0.92% 01 Jan 2015 31 Dec 2015 10-K 08 Mar 2018
2014 -$52.8M -$36.3M -220% 01 Jan 2014 31 Dec 2014 10-K 03 Mar 2017
2013 -$16.5M +$2.5M +13.1% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016
2012 -$19M +$3.45M +15.3% 01 Jan 2012 31 Dec 2012 10-K 26 Feb 2015
2011 -$22.5M -$5.57M -32.9% 01 Jan 2011 31 Dec 2011 10-K 12 Mar 2014
2010 -$16.9M 01 Jan 2010 31 Dec 2010 10-K 12 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.